drugset / Trial / NCT01621256
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Phase 1/2
Completed
31 enrolled
Nordmark Arzneimittel GmbH & Co. KG
ClinSupport GmbH · collabLCR Leading Clinical Research s.r.o. · collabMWI Medizinisches Wirtschaftsinstitut GmbH · collabProjectPharm s.r.o. · collabX-act Cologne Clinical Research GmbH · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether ancrod is effective and safe in the treatment of sudden sensorineural hearing loss (SSHL).
Timeline
- Start
- 2013-05
- Primary completion
- 2018-09-18
- Completion
- 2018-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ancrod | Unknown | — | Intravenous |